🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

GSK plc DRC (GSK)

NYSE
Currency in USD
33.95
-0.22(-0.64%)
Closed
After Hours
34.05+0.10(+0.29%)

GSK Income Statement

Advanced Income Statement
Period Ending:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa33,75424,35424,69629,32430,328
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+9.52%-27.85%+1.4%+18.74%+3.42%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa10,7927,3218,0339,4078,388
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa22,96217,03316,66319,91721,940
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+8.79%-25.82%-2.17%+19.53%+10.16%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa68.03%69.94%67.47%67.92%72.34%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa14,76110,98311,02912,59513,537
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+8.44%-25.59%+0.42%+14.2%+7.48%
aa.aaaa.aaaa.aaaa.aaaa.aa4,4054,3974,6275,1535,823
aa.aaaa.aaaa.aaaa.aaaa.aa10,9627,0416,7848,1799,156
aa.aaaa.aaaa.aaaa.aaaa.aa-606-455-382-737-1,442
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa8,2016,0505,6347,3228,403
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+9.42%-26.23%-6.88%+29.96%+14.76%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa24.3%24.84%22.81%24.97%27.71%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-798-818-749-757-602
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-17.01%-2.51%+8.44%-1.07%+20.48%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-877-844-762-819-710
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa79261362108
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa62927-48-80
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa7,4655,2414,9126,5177,721
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa5412,85755221561
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-661-1,508-1,442-1,039-1,215
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa6,2215,1703,5995,6286,064
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+29.6%-16.89%-30.39%+56.38%+7.75%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa18.43%21.23%14.57%19.19%19.99%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa9536783707756
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa5,2685,9794,58515,4165,308
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-623-230-200-460-380
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa4,6455,7494,38514,9564,928
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+28.21%+23.77%-23.73%+241.07%-67.05%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa13.76%23.61%17.76%51%16.25%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa4,6454,8733,3164,4614,928
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa1.171.220.831.111.22
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+27.35%+4.29%-32.33%+33.76%+9.76%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa1.161.210.821.091.2
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+27.02%+4.45%-32.34%+33.5%+9.8%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa3,957.63,9814,0034,0264,052
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa4,012.84,0304,0524,0844,111
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa1110.610.58
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa0%0%0%-38.75%-5.31%
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa10,3218,1007,7569,08910,304
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+10.37%-21.52%-4.25%+17.19%+13.37%
EBITDA Margin %
aa.aaaa.aa